Basin evaluation using burial history calculations: an overview
…, CGSC Kendall, I Lerche, DJ Toth… - AAPG …, 1985 - archives.datapages.com
… They formulated a relationship by assuming the incremental change in porosity (d^phgr/^phgr) …
For a layer thickness D(t) at depth z with a temperature on the top of the layer of T t (z), we …
For a layer thickness D(t) at depth z with a temperature on the top of the layer of T t (z), we …
Relapse, rebound, and psoriasis adverse events: an advisory group report
…, A Menter, K Papp, AC Rundle, D Toth - Journal of the American …, 2006 - Elsevier
… Toth D, Papp K. Managing recurrence of psoriasis following abrupt withdrawal from efalizumab
therapy. Poster 31 presented at: 10th Annual International Psoriasis Symposium; June 10…
therapy. Poster 31 presented at: 10th Annual International Psoriasis Symposium; June 10…
The pandemic potential of avian influenza A (H7N9) virus: a review
In March 2013 the first cases of human avian influenza A(H7N9) were reported to the World
Health Organization. Since that time, over 650 cases have been reported. Infections are …
Health Organization. Since that time, over 650 cases have been reported. Infections are …
Orthographic depth and its impact on universal predictors of reading: A cross-language investigation
Alphabetic orthographies differ in the transparency of their letter-sound mappings, with
English orthography being less transparent than other alphabetic scripts. The outlier status of …
English orthography being less transparent than other alphabetic scripts. The outlier status of …
[HTML][HTML] Phase 3 studies comparing brodalumab with ustekinumab in psoriasis
Background Early clinical studies suggested that the anti–interleukin-17 receptor A monoclonal
antibody brodalumab has efficacy in the treatment of psoriasis. Methods In two phase 3 …
antibody brodalumab has efficacy in the treatment of psoriasis. Methods In two phase 3 …
[HTML][HTML] A novel targeted T-cell modulator, efalizumab, for plaque psoriasis
…, SK Tyring, TK Hamilton, D Toth… - … England Journal of …, 2003 - Mass Medical Soc
Background Interactions between leukocyte-function–associated antigen type 1 (LFA-1) and
intercellular adhesion molecules are important in the pathogenesis of psoriasis. Efalizumab…
intercellular adhesion molecules are important in the pathogenesis of psoriasis. Efalizumab…
A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis
…, A Blauvelt, W Baran, C Bolduc, D Toth… - British Journal of …, 2016 - academic.oup.com
Background The interleukin‐17 cytokine family plays a central role in psoriasis
pathogenesis. Objectives To evaluate the efficacy and safety of brodalumab, a human anti‐interleukin‐17 …
pathogenesis. Objectives To evaluate the efficacy and safety of brodalumab, a human anti‐interleukin‐17 …
Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo …
JI Silverberg, D Toth, T Bieber, AF Alexis… - British Journal of …, 2021 - academic.oup.com
Background Tralokinumab is a fully human monoclonal antibody that specifically neutralizes
interleukin‐13, a key driver of atopic dermatitis (AD). Objectives To evaluate the efficacy …
interleukin‐13, a key driver of atopic dermatitis (AD). Objectives To evaluate the efficacy …
Predictors of developmental dyslexia in European orthographies with varying complexity
Background: The relationship between phoneme awareness, rapid automatized naming (RAN),
verbal short‐term/working memory (ST/WM) and diagnostic category is investigated in …
verbal short‐term/working memory (ST/WM) and diagnostic category is investigated in …
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study
KB Gordon, RG Langley, C Leonardi, D Toth… - Journal of the American …, 2006 - Elsevier
BACKGROUND: Tumor necrosis factor is pivotal in the pathogenesis of psoriasis.
Adalimumab is a fully human monoclonal immunoglobulin G 1 antibody that neutralizes tumor …
Adalimumab is a fully human monoclonal immunoglobulin G 1 antibody that neutralizes tumor …